These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10926300)

  • 21. A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse.
    Willemsen R; Tybulewicz V; Sidransky E; Eliason WK; Martin BM; LaMarca ME; Reuser AJ; Tremblay M; Westphal H; Mulligan RC
    Mol Chem Neuropathol; 1995; 24(2-3):179-92. PubMed ID: 7632321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease.
    Dai M; Liou B; Swope B; Wang X; Zhang W; Inskeep V; Grabowski GA; Sun Y; Pan D
    PLoS One; 2016; 11(9):e0162367. PubMed ID: 27598339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
    Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
    Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP
    Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses.
    Vitner EB; Dekel H; Zigdon H; Shachar T; Farfel-Becker T; Eilam R; Karlsson S; Futerman AH
    Hum Mol Genet; 2010 Sep; 19(18):3583-90. PubMed ID: 20616152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
    Chabás A; Gort L; Díaz-Font A; Montfort M; Santamaría R; Cidrás M; Grinberg D; Vilageliu L
    Blood Cells Mol Dis; 2005; 35(2):253-8. PubMed ID: 15967693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gaucher disease: complexity in a "simple" disorder.
    Sidransky E
    Mol Genet Metab; 2004; 83(1-2):6-15. PubMed ID: 15464415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
    Dekker N; van Dussen L; Hollak CE; Overkleeft H; Scheij S; Ghauharali K; van Breemen MJ; Ferraz MJ; Groener JE; Maas M; Wijburg FA; Speijer D; Tylki-Szymanska A; Mistry PK; Boot RG; Aerts JM
    Blood; 2011 Oct; 118(16):e118-27. PubMed ID: 21868580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
    Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
    Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global gene expression in a type 2 Gaucher disease brain.
    Myerowitz R; Mizukami H; Richardson KL; Finn LS; Tifft CJ; Proia RL
    Mol Genet Metab; 2004 Dec; 83(4):288-96. PubMed ID: 15589115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
    Bodennec J; Pelled D; Riebeling C; Trajkovic S; Futerman AH
    FASEB J; 2002 Nov; 16(13):1814-6. PubMed ID: 12223447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease.
    Farfel-Becker T; Vitner EB; Pressey SN; Eilam R; Cooper JD; Futerman AH
    Hum Mol Genet; 2011 Apr; 20(7):1375-86. PubMed ID: 21252206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease.
    Nilsson O; Svennerholm L
    J Neurochem; 1982 Sep; 39(3):709-18. PubMed ID: 7097276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 and type 3 Gaucher disease: a morphological and biochemical study.
    Kaye EM; Ullman MD; Wilson ER; Barranger JA
    Ann Neurol; 1986 Aug; 20(2):223-30. PubMed ID: 3752966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
    Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA
    Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucosylceramide and related compounds in normal tissues and in Gaucher disease.
    Suzuki K
    Prog Clin Biol Res; 1982; 95():219-30. PubMed ID: 7122635
    [No Abstract]   [Full Text] [Related]  

  • 37. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
    J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
    Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
    Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease.
    Kim EY; Hong YB; Go SH; Lee B; Jung SC
    Exp Mol Med; 2006 Aug; 38(4):348-56. PubMed ID: 16953113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.